Sun Pharmaceutical Industries Ltd. reached a new all-time high of ₹1,963 on July 21, 2026. The stock gained 0.36% during the session. This milestone occurred while the broader Sensex index recorded a decline.
Sun Pharma delivered a 15.77% return over the past year. In contrast, the Sensex fell by 5.88% during the same period. The stock currently trades above all its key moving averages.
Analysts expect robust domestic growth to cushion pricing pressures in the U.S. market. Strong fundamentals and positive technical indicators continue to support the pharmaceutical company's upward momentum.